Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Cactus, Inc. Q4 2025 Earnings Call - Cactus International Dampens Near-Term Margins, Material Synergies Targeted for 2027
Cactus closed 2025 with solid margins and cash, even as the newly acquired Cactus International business clouds near-term profitability. Q4 revenue was $261 million with Adjusted EBITDA of $85 million...
- Q4 2025 total revenue was $261 million, down 1% sequentially; Adjusted EBITDA was $85 million, down 1.7% sequentially; Adjusted EBITDA margin 32.7% (Q3 32.9%).
- Pressure Control outperformed sequentially, with Q4 revenue $178 million, up 5.8% sequentially; operating income rose $4.1 million (9.3%); segment EBITDA up 7.2% and margins improved about 50-90 bps depending on metric.
- Spoolable Technologies declined seasonally, Q4 revenue $84 million, down 11.6% sequentially; operating income fell $4.9 million (18.9%); adjusted EBITDA down 13.6% and margins compressed due to lower operating leverage.
- +13 more takeaways
SM Energy Q4 2025 Earnings Call - Prioritizing Free Cash Flow, Deleveraging and Returning Capital Post-Civitas Merger
SM Energy used its Q4 2025 results and 2026 outlook to frame a clear post-merger playbook: integrate Civitas, execute a lower-volume higher‑margin development plan, and bolster the balance sheet. Mana...
- Three strategic priorities: integrate the Civitas deal, execute a free cash flow focused program, and bolster the balance sheet.
- Merger synergies targeted at $200 million to $300 million; $185 million already actioned. Management says total synergies could unlock up to $1.5 billion in present value.
- 2026 plan built on commodity assumptions of $60 oil and $3.50 gas, with pro forma CapEx of $2.65 billion to $2.85 billion, about 14% lower than pro forma 2025.
- +12 more takeaways
Summit Hotel Properties Q4 2025 Earnings Call - Portfolio strength and balance-sheet fixes set stage for modest RevPAR recovery in 2026
Summit closed 2025 with steady operational traction despite a meaningful pullback in government and international inbound demand. Q4 showed a clear sequential inflection, with RevPAR trends improving ...
- Q4 2025 same-store RevPAR: management reported a 1.6% decline, while CFO cited a pro forma RevPAR decline of 1.8%, but both emphasize sharp sequential improvement versus Q2/Q3.
- Sequential improvement was meaningful: RevPAR trends improved by over 200 basis points sequentially in Q4, with the CFO noting a 240 basis-point improvement from Q3 to Q4.
- Government and international inbound demand remain the primary drag, representing roughly 10% to 15% of room nights and declining approximately 20% blended in Q4; excluding these segments, Q4 RevPAR grew about 60 basis points year-over-year.
- +12 more takeaways
Carriage Services 4Q 2025 Earnings Call - Rebuilt balance sheet, M&A-ready to drive compounding growth
Carriage closed 2025 with steady operational gains and a balance sheet they say is ready for growth. Q4 revenue rose to $105.5 million, driven by funeral volume recovery and a surge in cemetery pre-ne...
- Q4 revenue $105.5 million, up 8% year-over-year, with funeral revenue $61.1 million (+9.6%) and cemetery revenue $33.8 million (+18.4%).
- Funeral home operating volume was 10,571 in Q4, +6.8% year-over-year; average revenue per contract rose to $5,777, +2.6% year-over-year.
- Cemetery strength was powered by a 25.5% jump in pre-need cemetery sales production and a 15.6% increase in pre-need interment rights sold in Q4.
- +12 more takeaways
Burford Capital FY2025 Q4 2025 Earnings Call - New business surge sets up portfolio growth despite weaker-than-expected cash realizations
Burford delivered a breakout year for new business while falling short on cash realizations. Management booked a 39% jump in new definitive commitments, adding roughly $700 million of modeled realizat...
- New-business surge: Burford recorded a 39% increase in new definitive commitments in FY2025, adding roughly $700 million of modeled realizations and lifting modeled realizations to about $5.2 billion.
- Portfolio growth vs cash timing: The firm materially grew its base portfolio (20% year-over-year growth in the base portfolio metric) but realized less cash than in 2024 because the year lacked a few very large, lumpy outcomes.
- Realizations by count, not quality: Realization event count was almost flat (69 in 2025 vs 71 in 2024); the shortfall was dollars per event, not fewer active matters.
- +12 more takeaways
Ferrovial FY2025 Earnings Call - North American highways fuel record dividends and negative net debt, while NTO delayed to Fall 2026
Ferrovial closed FY2025 with clear winners and a busy playbook. Revenue rose to EUR 9.6 billion, adjusted EBITDA to EUR 1.5 billion, driven largely by North American highways and a very strong constru...
- Revenue €9.6 billion in FY2025, up 8.6% like-for-like; adjusted EBITDA €1.5 billion, up 12.2% like-for-like.
- Record dividends from projects reached €968 million, supporting negative net debt ex-infra projects of €1.3 billion.
- North American highways were the engine: 407 ETR revenue +17.8% and traffic +6.1% in 2025; U.S. managed lanes delivered double-digit revenue growth overall.
- +13 more takeaways
Novavax Q4 and Full Year 2025 Earnings Call - Partnering-led Pivot: Matrix-M Deals and Cash Runway to 2028
Novavax used 2025 to execute a strategic pivot away from pure commercial COVID operations toward licensing and R&D-led value creation anchored on its Matrix-M adjuvant. Results were mixed but directio...
- Novavax reported adjusted total revenue of $1.1 billion for full-year 2025, which includes approximately $625 million of primarily non-cash revenue from resolved APAs with Canada and New Zealand.
- Fourth quarter 2025 revenue was $147 million, up 67% year-over-year; Q4 breakdown: Nuvaxovid product sales $20 million, supply sales $19 million, and Sanofi licensing/royalties/other revenue $98 million (including $50 million in MAH transfer milestones and $28 million R&D reimbursement).
- The company delivered positive GAAP income for both Q4 and full-year 2025 and ended 2025 with $857 million in cash and accounts receivable. Management added $80 million of non-dilutive cash in Q1 2026 (including a $30 million Pfizer upfront and $50 million initial draw on a new $330 million MidCap credit facility).
- +10 more takeaways
Ramaco Resources Q4 2025 Earnings Call - Carbochlorination Pivot Recasts Brook Mine Economics Toward Gallium and HPA
Ramaco used the quarter to do two things investors like, and one thing that forces patience. On the coal side they tightened the screws, producing the lowest cash costs since 2021, record liquidity, a...
- Flow sheet pivot: Ramaco is switching Brook Mine processing to a carbochlorination flow sheet, a high temperature carbon and chlorine route, with initial tests showing nearly all gallium volatilizes into the chloride stream.
- Product mix shift: The new flow sheet increases emphasis on high-purity gallium, high-purity alumina, and high-purity quartz, while reducing the relative contribution from scandium and the degree of downstream rare earth separation required.
- De-risk and cost profile: Management says carbochlorination reduces capital and operating costs versus the prior solvent extraction route, removes bulk reagent needs, and should improve overall recoveries and basket pricing, subject to third-party validation.
- +12 more takeaways
Hertz Global Holdings Q4 2025 Earnings Call - Back-to-Basics drove revenue rebound but Q4 hit by recalls, residuals and shutdowns
Hertz says 2025 was the year of Back-to-Basics: fleet rotation, tighter cost control, better pricing and a big lift in customer satisfaction. The strategy produced more than $1 billion of Adjusted EBI...
- Full-year 2025 delivered over $1.0 billion of Adjusted EBITDA improvement year-over-year, driven by fleet discipline, revenue optimization and cost control.
- Q4 2025 Adjusted EBITDA improved about $150 million year-over-year but was approximately negative $200 million reported, roughly $100 million short of internal targets.
- Q4 revenue of $2.0 billion came in ahead of consensus; RPD was broadly in line and down roughly 1% year-over-year, and revenue was nearly flat on a loyalty-adjusted basis versus a year ago.
- +17 more takeaways
Kinetik Holdings Q4 2025 Earnings Call - 2026 Rebuild: $1B EBITDA Midpoint and Execution to Restore Credibility
Kinetik closed a bruising 2025 with adjusted EBITDA of $988 million and Q4 EBITDA of $252 million, and labeled 2026 a rebuilding year focused on execution, disciplined capital allocation, and transpar...
- Q4 2025 adjusted EBITDA was $252 million, full-year adjusted EBITDA was $988 million, slightly above the midpoint of revised guidance.
- 2026 adjusted EBITDA guidance is $950 million to $1.05 billion, midpoint $1.0 billion, which management says implies over 7% YoY growth when normalizing for the EPIC Crude divestiture.
- Free cash flow was negative $12 million in Q4; distributable cash flow for Q4 was $152 million.
- +16 more takeaways